JP2019526274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526274A5 JP2019526274A5 JP2019524114A JP2019524114A JP2019526274A5 JP 2019526274 A5 JP2019526274 A5 JP 2019526274A5 JP 2019524114 A JP2019524114 A JP 2019524114A JP 2019524114 A JP2019524114 A JP 2019524114A JP 2019526274 A5 JP2019526274 A5 JP 2019526274A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- protein
- fusion protein
- msp3
- antigenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022085159A JP7579298B2 (ja) | 2016-07-21 | 2022-05-25 | 抗マラリアワクチンとしてのバイオ融合タンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16180544.5 | 2016-07-21 | ||
| EP16180544 | 2016-07-21 | ||
| PCT/SG2017/050369 WO2018017020A1 (en) | 2016-07-21 | 2017-07-21 | Biofusion proteins as anti-malaria vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022085159A Division JP7579298B2 (ja) | 2016-07-21 | 2022-05-25 | 抗マラリアワクチンとしてのバイオ融合タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019526274A JP2019526274A (ja) | 2019-09-19 |
| JP2019526274A5 true JP2019526274A5 (https=) | 2020-08-27 |
Family
ID=56550732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524114A Pending JP2019526274A (ja) | 2016-07-21 | 2017-07-21 | 抗マラリアワクチンとしてのバイオ融合タンパク質 |
| JP2022085159A Active JP7579298B2 (ja) | 2016-07-21 | 2022-05-25 | 抗マラリアワクチンとしてのバイオ融合タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022085159A Active JP7579298B2 (ja) | 2016-07-21 | 2022-05-25 | 抗マラリアワクチンとしてのバイオ融合タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210038706A1 (https=) |
| EP (2) | EP3487526B1 (https=) |
| JP (2) | JP2019526274A (https=) |
| KR (2) | KR20240154691A (https=) |
| CN (1) | CN109963586B (https=) |
| AU (1) | AU2017300965B2 (https=) |
| BR (1) | BR112019001115A2 (https=) |
| CA (1) | CA3031399A1 (https=) |
| TW (1) | TWI780058B (https=) |
| WO (1) | WO2018017020A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020017962A1 (en) * | 2018-07-16 | 2020-01-23 | Dcprime B.V. | A combination product for use in tumor vaccination. |
| WO2020033398A1 (en) * | 2018-08-06 | 2020-02-13 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for treating atii cell-dependent lung diseases |
| ES3016535T3 (en) * | 2018-11-23 | 2025-05-09 | Strike Pharma Ab | Bi-specific conjugates |
| CA3133410A1 (en) | 2019-04-25 | 2020-10-29 | Dcprime B.V. | Methods of tumor vaccination |
| NL2023863B1 (en) * | 2019-09-20 | 2021-05-25 | Univ Griffith | Protein particles and uses thereof |
| CN111135290A (zh) * | 2020-01-16 | 2020-05-12 | 定山石生物科技(北京)有限公司 | 一种用于激活人体免疫细胞的多肽试剂 |
| CN115916963A (zh) | 2020-03-27 | 2023-04-04 | 门德斯有限公司 | 白血病来源的经修饰细胞用于增强过继性细胞治疗的效力的离体用途 |
| EP4171617A1 (en) | 2020-06-30 | 2023-05-03 | Mendus B.V. | Use of leukemia-derived cells in ovarian cancer vaccines |
| JP2024506249A (ja) | 2021-01-22 | 2024-02-13 | メンドゥス・ベスローテン・フェンノートシャップ | 腫瘍ワクチン接種の方法 |
| BE1029148B1 (fr) * | 2021-02-26 | 2022-09-26 | Curavac Europe | Vaccin pour un traitement therapeutique ou prophylactique de la myastenie grave |
| CN118207228B (zh) * | 2024-03-21 | 2025-03-14 | 中国科学院上海免疫与感染研究所 | 一种防治结合的多时期双靶点串联疟疾mRNA疫苗 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1156825A2 (en) * | 1999-02-25 | 2001-11-28 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
| DK200201741A (da) * | 2002-11-12 | 2003-09-16 | Statens Seruminstitut | Vaccine comprising chimeric malaria proteins derived from Plasmodium falciparum |
| US20050112133A1 (en) * | 2003-10-24 | 2005-05-26 | Pierre Druilhe | GLURP-MSP3 fusion protein, immunogenic compositions and malarial vaccines containing it |
| JP4696079B2 (ja) * | 2003-12-17 | 2011-06-08 | ヤンセン アルツハイマー イミュノセラピー | Ａβ免疫原性ペプチド担体結合物およびそれの製造方法 |
| KR101895768B1 (ko) * | 2011-06-01 | 2018-09-07 | 시아먼 유니버시티 | 디프테리아 독소 무독성 돌연변이 씨알엠197 또는 그의 단편을 포함하는 융합 단백질 |
| WO2014136064A2 (en) * | 2013-03-08 | 2014-09-12 | Pfizer Inc. | Immunogenic fusion polypeptides |
-
2017
- 2017-07-21 BR BR112019001115A patent/BR112019001115A2/pt unknown
- 2017-07-21 EP EP17746213.2A patent/EP3487526B1/en active Active
- 2017-07-21 TW TW106124623A patent/TWI780058B/zh active
- 2017-07-21 KR KR1020247034516A patent/KR20240154691A/ko active Pending
- 2017-07-21 US US16/319,078 patent/US20210038706A1/en not_active Abandoned
- 2017-07-21 CN CN201780051251.4A patent/CN109963586B/zh active Active
- 2017-07-21 AU AU2017300965A patent/AU2017300965B2/en active Active
- 2017-07-21 WO PCT/SG2017/050369 patent/WO2018017020A1/en not_active Ceased
- 2017-07-21 KR KR1020197005103A patent/KR20190090775A/ko not_active Ceased
- 2017-07-21 CA CA3031399A patent/CA3031399A1/en not_active Abandoned
- 2017-07-21 EP EP22182920.3A patent/EP4147715A1/en active Pending
- 2017-07-21 JP JP2019524114A patent/JP2019526274A/ja active Pending
-
2022
- 2022-05-25 JP JP2022085159A patent/JP7579298B2/ja active Active
- 2022-07-06 US US17/858,642 patent/US20220409712A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526274A5 (https=) | ||
| US11771755B2 (en) | Self-asssembling nanostructure vaccines | |
| Stover et al. | Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. | |
| JP2023524054A (ja) | ベータコロナウイルスの予防と治療 | |
| CN105792842A (zh) | 埃巴病毒疫苗 | |
| JP2015509707A5 (https=) | ||
| CN113301918B (zh) | Cmv的通过融合修饰的病毒样颗粒 | |
| CN115850506B (zh) | 一种cd4辅助性t细胞表位融合肽及其疫苗 | |
| US8580274B2 (en) | Drug transporter, and adjuvant and vaccine each utilizing same | |
| ES2236718T3 (es) | Proteina portadora de efecto adyuvante, complejo inmunogenico que la contiene, su procedimiento de preparacion, secuencia nucleotidica y vacuna. | |
| Haeuw et al. | The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides | |
| CN110548135B (zh) | 磷酸化多肽抗原疫苗及其制备方法和应用 | |
| JPH10509325A (ja) | 粘膜免疫を刺激する免疫原 | |
| Shivachandra et al. | Immunogenicity of recombinant Omp16 protein of Pasteurella multocida B: 2 in mouse model | |
| EP4415753A1 (en) | Engineering antigen binding to, and orientation on, adjuvants for enhanced humoral responses and immunofocusing | |
| TWI683668B (zh) | 用於免疫作用中有效抗體生産的新穎蛋白質結構 | |
| Ohtake et al. | Recombinant therapeutic protein vaccines | |
| CN113801206A (zh) | 利用受体识别域诱导抗新冠病毒中和抗体的方法 | |
| JP2000000099A (ja) | ヘモフィルスインフルエンザｂ型菌の外皮膜タンパク質Ｐ２の部分断片を用いた接合体 | |
| CN106337038B (zh) | 一种通过转肽酶剪切制备疫苗的方法及其应用 | |
| US11535651B2 (en) | Hepatitis B nanoparticle-based vaccine for influenza virus | |
| CN116813793B (zh) | 融合蛋白以及其应用 | |
| JP6590916B2 (ja) | 毒素原性大腸菌およびジェジュニ菌の組合せの組換えコンストラクト | |
| Montaner et al. | Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route | |
| Kamzina et al. | Virus-like particles presenting conformational epitopes as a promising vaccine platform |